Lenka Fědorová

Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness

Beatrix Bencsiková, Eva Budínská, Iveta Selingerová et al. · BMC Cancer · 2019 · 18 citations · Full text

Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome

Eva Hlaváčková, Kateřina Pilátová, Dáša Černá et al. · Frontiers in Oncology · 2019 · 17 citations · Full text

Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma

Lenka Fědorová, Peter Múdry, Kateřina Pilátová et al. · Frontiers in Oncology · 2019 · 16 citations · Full text

Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening

J Vyskočil, Štěpán Tuček, Igor Kišš et al. · International Immunopharmacology · 2019 · 14 citations

Oxaliplatin Rechallenge, Allergy, Immunotoxicology +6

Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer – Exploratory Analysis of Their Biomarker Potential

Lenka Fědorová, Kateřina Pilátová, Iveta Selingerová et al. · Klinicka onkologie · 2018 · 10 citations · Full text